JP2012510439A - ジクロフェナクおよびヒドロキシ脂肪酸ポリオキシアルキレンエステルを含む医薬製剤 - Google Patents
ジクロフェナクおよびヒドロキシ脂肪酸ポリオキシアルキレンエステルを含む医薬製剤 Download PDFInfo
- Publication number
- JP2012510439A JP2012510439A JP2011537921A JP2011537921A JP2012510439A JP 2012510439 A JP2012510439 A JP 2012510439A JP 2011537921 A JP2011537921 A JP 2011537921A JP 2011537921 A JP2011537921 A JP 2011537921A JP 2012510439 A JP2012510439 A JP 2012510439A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- polyethylene glycol
- peg
- diclofenac
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
医薬製剤1は、Dolaut(商標)の商標名でGienne Pharma社より販売された市販の医薬製剤とした。
ジクロフェナクナトリウムの定量のために、H. Ka'hlig, et al, "Rheology and NMR self-diffusion experiments as well as skin permeation of diclofenac-sodium and cyproterone acetate of new gel preparations" , J. Pharm. Sci. 94 288-296 (2005)に記載の方法を用いた。
ストック溶液:2.281mg/mlのメタノール
カラム:Nucleosil C18
移動相:アセトニトリル/リン酸-緩衝液 pH=5(40:60/v:v)
UV-検出 λmax:230nm
流速:1.0ml/min
保持時間:約10分
ブタ腹部の皮膚を剃毛し、その後1.2 mmに設定した採皮刀(GB 228R, Aesculap)を用いて調製した。皮膚を使用するまで冷凍庫に-20℃で保存した。実験の2時間前に、サンプルを解凍した。
約1 cm2の透過領域を有するフランツ型拡散セル(Permegear(パーメギア), USA)およびブタの皮膚を用いて、標準的な拡散実験を行った。レセプターコンパートメントを2mlの0.012Mリン酸緩衝液(pH 7.4)で満たした。切除した皮膚を、角質層が最上層、すなわち、腹部側がレセプターコンパートメントに面するようにセルに載せた。拡散セルを、皮膚表面温度の32℃に保ち、磁気撹拌子により撹拌した。所定の時間間隔(2、4、6、8および24時間)で、アクセプター媒質を分析用に取り出し、新たなアクセプター媒質で置換した。所要に応じて、アクセプター媒質での適当な希釈を追加的に行った。投与された製剤の各量は、10mgのジクロフェナクナトリウムに相当した。3つの並列試験を、各産物について行った。以下の表および図1に、試験の平均結果および標準偏差を示す。
Claims (17)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08170177 | 2008-11-28 | ||
EP08170177.3 | 2008-11-28 | ||
PCT/EP2009/064971 WO2010060798A1 (en) | 2008-11-28 | 2009-11-11 | Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2012510439A true JP2012510439A (ja) | 2012-05-10 |
Family
ID=40512558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011537921A Pending JP2012510439A (ja) | 2008-11-28 | 2009-11-11 | ジクロフェナクおよびヒドロキシ脂肪酸ポリオキシアルキレンエステルを含む医薬製剤 |
Country Status (15)
Country | Link |
---|---|
US (1) | US20110275717A1 (ja) |
EP (1) | EP2364140A1 (ja) |
JP (1) | JP2012510439A (ja) |
KR (1) | KR20110091862A (ja) |
CN (1) | CN102227211A (ja) |
AU (1) | AU2009319167A1 (ja) |
BR (1) | BRPI0921654A2 (ja) |
CA (1) | CA2742645A1 (ja) |
CL (1) | CL2011001225A1 (ja) |
EA (1) | EA201100863A1 (ja) |
IL (1) | IL212602A0 (ja) |
MX (1) | MX2011005410A (ja) |
NZ (1) | NZ592647A (ja) |
WO (1) | WO2010060798A1 (ja) |
ZA (1) | ZA201103335B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015522049A (ja) * | 2012-07-12 | 2015-08-03 | フェリング ベスローテン フェンノートシャップ | ジクロフェナク製剤 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2666398C (en) | 2006-10-17 | 2015-08-18 | Ed Kisak | Diclofenac gel |
US8546450B1 (en) | 2009-03-31 | 2013-10-01 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
ITMI20121205A1 (it) | 2012-07-11 | 2014-01-12 | Glycores 2000 Srl | Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione |
US20140187635A1 (en) | 2012-12-28 | 2014-07-03 | Themis Medicare Limited | Diclofenac compositions |
CN104274436B (zh) * | 2013-07-03 | 2017-05-10 | 成都力思特制药股份有限公司 | 双氯芬酸钠盐酸利多卡因复方药物注射液及其制备方法 |
KR101524473B1 (ko) * | 2014-12-22 | 2015-06-02 | 주식회사 한국팜비오 | 주사제 조성물 |
KR101654900B1 (ko) * | 2016-02-04 | 2016-09-07 | 주식회사 한국루베 | 저독성 화생방 제독제 |
WO2021048748A1 (en) | 2019-09-09 | 2021-03-18 | Ftf Pharma Private Limited | Pharmaceutical formulations comprising diclofenac |
CN112516081B (zh) * | 2020-12-16 | 2023-03-10 | 郑州百瑞动物药业有限公司 | 一种双氯芬酸注射液及其制备方法 |
EP4112042A1 (en) * | 2021-06-30 | 2023-01-04 | GSK Consumer Healthcare SARL | Nanoemulsion comprising diclofenac |
WO2023180792A1 (en) | 2022-03-25 | 2023-09-28 | Glycores 2000 Srl | Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10182450A (ja) * | 1996-12-27 | 1998-07-07 | Ss Pharmaceut Co Ltd | 外用組成物 |
JP2002510329A (ja) * | 1997-07-29 | 2002-04-02 | ファルマシア・アンド・アップジョン・カンパニー | 親油性化合物用の自己乳化性処方 |
JP2004238399A (ja) * | 1999-08-17 | 2004-08-26 | Galena As | 経口及び局所投与用の医薬組成物 |
WO2006056889A2 (en) * | 2004-10-06 | 2006-06-01 | Tiltan Pharma Ltd | Method and composition for enhancing anti-angiogenic therapy |
WO2008004231A1 (en) * | 2006-07-07 | 2008-01-10 | Tiltan Pharma Ltd. | Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent |
JP2008255115A (ja) * | 2007-03-23 | 2008-10-23 | Axxonis Pharma Ag | エルゴリン化合物の安定化された水溶液 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH655656B (ja) * | 1982-10-07 | 1986-05-15 | ||
EP0420798B1 (de) * | 1989-09-21 | 1994-03-23 | Ciba Vision AG, Hettlingen | Antimikrobielle Zusammensetzungen |
-
2009
- 2009-11-11 JP JP2011537921A patent/JP2012510439A/ja active Pending
- 2009-11-11 WO PCT/EP2009/064971 patent/WO2010060798A1/en active Application Filing
- 2009-11-11 US US13/128,747 patent/US20110275717A1/en not_active Abandoned
- 2009-11-11 CA CA2742645A patent/CA2742645A1/en not_active Abandoned
- 2009-11-11 AU AU2009319167A patent/AU2009319167A1/en not_active Abandoned
- 2009-11-11 EP EP09748800A patent/EP2364140A1/en not_active Withdrawn
- 2009-11-11 NZ NZ592647A patent/NZ592647A/xx not_active IP Right Cessation
- 2009-11-11 EA EA201100863A patent/EA201100863A1/ru unknown
- 2009-11-11 CN CN2009801474197A patent/CN102227211A/zh active Pending
- 2009-11-11 BR BRPI0921654A patent/BRPI0921654A2/pt not_active IP Right Cessation
- 2009-11-11 KR KR1020117012471A patent/KR20110091862A/ko not_active Application Discontinuation
- 2009-11-11 MX MX2011005410A patent/MX2011005410A/es not_active Application Discontinuation
-
2011
- 2011-05-01 IL IL212602A patent/IL212602A0/en unknown
- 2011-05-06 ZA ZA2011/03335A patent/ZA201103335B/en unknown
- 2011-05-26 CL CL2011001225A patent/CL2011001225A1/es unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10182450A (ja) * | 1996-12-27 | 1998-07-07 | Ss Pharmaceut Co Ltd | 外用組成物 |
JP2002510329A (ja) * | 1997-07-29 | 2002-04-02 | ファルマシア・アンド・アップジョン・カンパニー | 親油性化合物用の自己乳化性処方 |
JP2004238399A (ja) * | 1999-08-17 | 2004-08-26 | Galena As | 経口及び局所投与用の医薬組成物 |
WO2006056889A2 (en) * | 2004-10-06 | 2006-06-01 | Tiltan Pharma Ltd | Method and composition for enhancing anti-angiogenic therapy |
WO2008004231A1 (en) * | 2006-07-07 | 2008-01-10 | Tiltan Pharma Ltd. | Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent |
JP2008255115A (ja) * | 2007-03-23 | 2008-10-23 | Axxonis Pharma Ag | エルゴリン化合物の安定化された水溶液 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015522049A (ja) * | 2012-07-12 | 2015-08-03 | フェリング ベスローテン フェンノートシャップ | ジクロフェナク製剤 |
JP2018048140A (ja) * | 2012-07-12 | 2018-03-29 | フェリング ベスローテン フェンノートシャップ | ジクロフェナク製剤 |
US9999590B2 (en) | 2012-07-12 | 2018-06-19 | Ferring B.V. | Diclofenac formulations |
Also Published As
Publication number | Publication date |
---|---|
EA201100863A1 (ru) | 2011-12-30 |
CL2011001225A1 (es) | 2011-11-11 |
MX2011005410A (es) | 2011-06-16 |
BRPI0921654A2 (pt) | 2016-02-10 |
US20110275717A1 (en) | 2011-11-10 |
ZA201103335B (en) | 2012-01-25 |
AU2009319167A1 (en) | 2010-06-03 |
CA2742645A1 (en) | 2010-06-03 |
CN102227211A (zh) | 2011-10-26 |
KR20110091862A (ko) | 2011-08-16 |
IL212602A0 (en) | 2011-07-31 |
NZ592647A (en) | 2013-05-31 |
WO2010060798A1 (en) | 2010-06-03 |
EP2364140A1 (en) | 2011-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012510439A (ja) | ジクロフェナクおよびヒドロキシ脂肪酸ポリオキシアルキレンエステルを含む医薬製剤 | |
US8470886B2 (en) | Topical ibuprofen formulations | |
EP2131813B1 (en) | Topical pharmaceutical formulation | |
JP3356455B2 (ja) | ケトプロフェンリジン塩を含む局所用親水性医薬組成物 | |
JP2001509136A (ja) | ウマ蹄葉炎の治療 | |
JPS5989621A (ja) | 薬剤組成物 | |
EP2515866B1 (en) | Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue | |
CA2785249A1 (en) | Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture | |
CN111491625B (zh) | 溶解尿酸单钠以治疗痛风 | |
EP2019666B1 (en) | Pharmaceutical preparations for transdermal use | |
US20180078495A1 (en) | Skin Penetration Enhancing Systems for Polar Drugs | |
US9254296B2 (en) | Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture | |
EP2405892B1 (en) | Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid | |
WO2021178834A1 (en) | Topical pharmaceutical formulations of a cyclic depsipeptide | |
JP4895458B2 (ja) | 経皮吸収促進剤およびその使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120914 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20130523 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20130523 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131127 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140227 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140306 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140327 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140403 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140527 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20141001 |